- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07593287
PEDİATRİC MİGRAİNE PATİENTS İN FİNDİNGS
EVALUATİON OF POSTDROME FİNDİNGS İN PEDAİTRİC MİGRAİNE PATİENTS
Migraine is a common neurological disease in the pediatric population. However, studies investigating the clinical symptoms associated with the different phases of migraine attacks (prodrome, aura, postdrome), particularly in childhood and adolescence, remain limited. The aim of this study was to evaluate the clinical symptoms experienced by children with migraine during attack phases (prodrome, aura, postdrome) and to investigate potential differences in these symptoms according to age and gender The first 18 questions assessed sociodemographic variables, including age, sex, body weight, parental characteristics, social status, age at migraine diagnosis and symptoms, knowledge of migraine, family history of migraine, comorbid conditions, and access to healthcare services. The second part of the questionnaire consisted of questions on headache and migraine-related symptoms and clinical characteristics (questions 19-26), migraine treatment (questions 28-34), and postdrome features (questions 35-39). The study examined migraine-related symptoms and clinical characteristics, treatment approaches, and the influence of sex and age group on the stages of migraine.
All patients underwent an assessment of headaches within the last three months, along with physical and neurological examinations. The diagnosis of migraine was made according to the ICHD-III criteria.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Balıkesir, Tyrkia (Türkiye), 10145
- Balikesir University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
İnclusion criteria
• Migraine
Exclusion Criteria:
- Primary headaches
- Hemiplegic migraine
- Depression
- Anxiety
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Pediatric Migraine Patients
Patients with non-migraine primary headaches, hemiplegic migraine, medication overuse, language or cognitive impairments, medical or psychiatric disorders, those older than 18 years of age, and those who were unwilling to participate in the study were exclude
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Reporting post-migraine symptoms according to age and gender.
Tidsramme: Between 01.04.2021 and 01.09.2021
|
The aim of this study is to report clinical findings observed during the postdrome period (prodrome, aura, and headache) and at other times following childhood migraine attacks, according to gender and age.
|
Between 01.04.2021 and 01.09.2021
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Balikesir University Pediatric
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .